Contemporary strategies in the management of hepatocellular carcinoma

HPB Surgery

Volumn 2012, Issue , 2012, Pages

  Khorsandi, Shirin Elizabeth ^a   Heaton, Nigel ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84870040428     PISSN: 08948569     EISSN: 16078462     Source Type: Journal    
DOI: 10.1155/2012/154056     Document Type: Review

References (87)

1. El-Serag H. B., Mason A. C., Rising incidence of hepatocellular carcinoma in the United States. The New England Journal of Medicine 1999 340 10 745 750 2-s2.0-0033545541 10.1056/NEJM199903113401001
2. Bosch F. X., Ribes J., Díaz M., Cléries R., Primary liver cancer: worldwide incidence and trends. Gastroenterology 2004 127 supplement 1 S5 S16 2-s2.0-7044229778 10.1053/j.gastro.2004.09.011
3. El-Serag H. B., Rudolph K. L., Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007 132 7 2557 2576 2-s2.0-34250020201 10.1053/j.gastro.2007.04.061
4. Samuel D., Colombo M., El-Serag H., Sobesky R., Heaton N., Toward optimizing the indications for orthotopic liver transplantation in hepatocellular carcinoma. Liver Transplantation 2011 17 supplement 2 S6 S13
5. Santi V., Trevisani F., Gramenzi A., Grignaschi A., Mirici-Cappa F., Poggio P. D., Nolfo M. A. D., Benvegn L., Farinati F., Zoli M., Giannini E. G., Borzio F., Caturelli E., Chiaramonte M., Bernardi M., Semiannual surveillance is superior to annual surveillance for the detection of early hepatocellular carcinoma and patient survival. Journal of Hepatology 2010 53 2 291 297 2-s2.0-77955306863 10.1016/j.jhep.2010.03.010
6. Llovet J. M., Fuster J., Bruix J., Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology 1999 30 6 1434 1440 2-s2.0-0032742183
7. Franco D., Capussotti L., Smadja C., Bouzari H., Meakins J., Kemeny F., Grange D., Dellepiane M., Resection of hepatocellular carcinomas. Reults in 72 European patients with cirrhosis. Gastroenterology 1990 98 3 733 738 2-s2.0-0025019712
8. Okada S., Shimada K., Yamamoto J., Takayama T., Kosuge T., Yamasaki S., Sakamoto M., Hirohashi S., Predictive factors for postoperative recurrence of hepatocellular carcinoma. Gastroenterology 1994 106 6 1618 1624 2-s2.0-0028241648
9. Minagawa M., Makuuchi M., Takayama T., Kokudo N., Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma. Annals of Surgery 2003 238 5 703 710 2-s2.0-0642338431 10.1097/01.sla.0000094549.11754. e6
10. Poon R. T. P., Fan S. T., Lo C. M., Liu C. L., Wong J., Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors. Annals of Surgery 1999 229 2 216 222 2-s2.0-0033503797 10.1097/00000658-199902000-00009
11. O'Grady J. G., Polson R. J., Rolles K., Calne R. Y., Williams R., Liver transplantation for malignant disease. Annals of Surgery 1988 207 4 373 379 2-s2.0-0023934781
12. Ringe B., Pichlmayr R., Wittekind C., Tusch G., Surgical treatment of hepatocellular carcinoma: experience with liver resection and transplantation in 198 patients. World Journal of Surgery 1991 15 2 270 285 2-s2.0-0025891345
13. Moreno P., Jaurrieta E., Figueras J., Benasco C., Rafecas A., Fabregat J., Torras J., Casanovas T., Casais L., Orthotopic liver transplantation: treatment of choice in cirrhotic patients with hepatocellular carcinoma? Transplantation Proceedings 1995 27 4 2296 2298 2-s2.0-0029101520
14. Mazzaferro V., Regalia E., Doci R., Andreola S., Pulvirenti A., Bozzetti F., Montalto F., Ammatuna M., Morabito A., Gennari L., Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. The New England Journal of Medicine 1996 334 11 693 699 2-s2.0-0345299824 10.1056/NEJM199603143341104
15. Olthoff K. M., Forner A., Hübscher S., Fung J., What is the best staging system for hepatocellular carcinoma in the setting of liver transplantation? Liver Transplantation 2011 17 supplement 2 S26 S33
16. Yao F. Y., Ferrell L., Bass N. M., Watson J. J., Bacchetti P., Venook A., Ascher N. L., Roberts J. P., Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 2001 33 6 1394 1403 2-s2.0-0034991518 10.1053/jhep.2001. 24563
17. Mazzaferro V., Llovet J. M., Miceli R., Bhoori S., Schiavo M., Mariani L., Camerini T., Roayaie S., Schwartz M. E., Grazi G. L., Adam R., Neuhaus P., Salizzoni M., Bruix J., Forner A., De Carlis L., Cillo U., Burroughs A. K., Troisi R., Rossi M., Gerunda G. E., Lerut J., Belghiti J., Boin I., Gugenheim J., Rochling F., Van Hoek B., Majno P., Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. The Lancet Oncology 2009 10 1 35 43 2-s2.0-57749191711 10.1016/S1470-2045(08)70284-5
18. Roayaie S., Frischer J. S., Emre S. H., Fishbein T. M., Sheiner P. A., Sung M., Miller C. M., Schwartz M. E., Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters. Annals of Surgery 2002 235 4 533 539 2-s2.0-0036202371 10.1097/00000658-200204000-00012
19. Kneteman N. M., Oberholzer J., Al Saghier M., Meeberg G. A., Blitz M., Ma M. M., Wong W. W. S., Gutfreund K., Mason A. L., Jewell L. D., Shapiro A. M. J., Bain V. G., Bigam D. L., Sirolimus-based immunosuppression for liver transplantation in the presence of extended criteria for hepatocellular carcinoma. Liver Transplantation 2004 10 10 1301 1311 2-s2.0-6444233347 10.1002/lt.20237
20. Majno P. E., Sarasin F. P., Mentha G., Hadengue A., Primary liver resection and salvage transplantation or primary liver transplantation in patients with single, small hepatocellular carcinoma and preserved liver function: an outcome-oriented decision analysis. Hepatology 2000 31 4 899 906 2-s2.0-0034077090
21. Fuks D., Dokmak S., Paradis V., Diouf M., Durand F., Belghiti J., Benefit of initial resection of hepatocellular carcinoma followed by transplantation in case of recurrence: an intention-to-treat analysis. Hepatology 2012 55 1 132 140
22. Adam R., Azoulay D., Castaing D., Eshkenazy R., Pascal G., Hashizume K., Samuel D., Bismuth H., DeMatteo R. P., Pitt H. A., Busuttil R. W., Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy? Annals of Surgery 2003 238 4 508 519 2-s2.0-10744220026
23. Majno P. E., Adam R., Bismuth H., Castaing D., Ariche A., Krissat J., Perrin H., Azoulay D., Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis. Annals of Surgery 1997 226 6 688 703 2-s2.0-0031474934 10.1097/00000658-199712000-00006
24. Graziadei I. W., Sandmueller H., Waldenberger P., Koenigsrainer A., Nachbaur K., Jaschke W., Margreiter R., Vogel W., Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome. Liver Transplantation 2003 9 6 557 563 2-s2.0-0038173318 10.1053/jlts.2003.50106
25. Yao F. Y., Breitenstein S., Broelsch C. E., Does a patient qualify for liver transplantation after the down-staging of hepatocellular carcinoma? Liver Transplantation 2011 17 supplement 2 S109 S116
26. Barakat O., Wood R. P., Ozaki C. F., Ankoma-Sey V., Galati J., Skolkin M., Toombs B., Round M., Moore W., Mieles L., Morphological features of advanced hepatocellular carcinoma as a predictor of downstaging and liver transplantation: an intention-to-treat analysis. Liver Transplantation 2010 16 3 289 299 2-s2.0-77749320242 10.1002/lt.21994
27. Yao F. Y., Kerlan R. K. Jr., Hirose R., Davern T. J., Bass N. M., Feng S., Peters M., Terrault N., Freise C. E., Ascher N. L., Roberts J. P., Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis. Hepatology 2008 48 3 819 827 2-s2.0-51349117878 10.1002/hep.22412
28. Lau W. Y., Lai E. C. H., Salvage surgery following downstaging of unresectable hepatocellular carcinoma-a strategy to increase resectability. Annals of Surgical Oncology 2007 14 12 3301 3309 2-s2.0-36349019179 10.1245/s10434-007-9549-7
29. Ravaioli M., Grazi G. L., Piscaglia F., Trevisani F., Cescon M., Ercolani G., Vivarelli M., Golfieri R., D'Errico Grigioni A., Panzini I., Morelli C., Bernardi M., Bolondi L., Pinna A. D., Liver transplantation for hepatocellular carcinoma: results of down-staging in patients initially outside the Milan selection criteria. American Journal of Transplantation 2008 8 12 2547 2557 2-s2.0-55949123393 10.1111/j.1600-6143.2008.02409.x
30. Lewandowski R. J., Kulik L. M., Riaz A., Senthilnathan S., Mulcahy M. F., Ryu R. K., Ibrahim S. M., Sato K. T., Baker T., Miller F. H., Omary R., Abecassis M., Salem R., A comparative analysis of transarterial downstaging for hepatocellular carcinoma: chemoembolization versus radioembolization. American Journal of Transplantation 2009 9 8 1920 1928 2-s2.0-67650938388 10.1111/j.1600-6143.2009.02695.x
31. Kulik L., Abecassis M., Living donor liver transplantation for hepatocellular carcinoma. Gastroenterology 2004 127 supplement 1 S277 S282 2-s2.0-7044233345 10.1053/j.gastro.2004.09.042
32. Di Sandro S., Slim A. O., Giacomoni A., Lauterio A., Mangoni I., Aseni P., Pirotta V., Aldumour A., Mihaylov P., De Carlis L., Living donor liver transplantation for hepatocellular carcinoma: long-term results compared with deceased donor liver transplantation. Transplantation Proceedings 2009 41 4 1283 1285 2-s2.0-65549122857 10.1016/j.transproceed.2009.03.022
33. Vakili K., Pomposelli J. J., Cheah Y. L., Akoad M., Lewis W. D., Khettry U., Gordon F., Khwaja K., Jenkins R., Pomfret E. A., Living donor liver transplantation for hepatocellular carcinoma: Increased recurrence but improved survival. Liver Transplantation 2009 15 12 1861 1866 2-s2.0-71249088799 10.1002/lt.21940
34. Mangus R. S., Fridell J. A., Vianna R. M., Cooper A. B., Jones D. T., Tector A. J., Use of the piggyback hepatectomy technique in liver transplant recipients with hepatocellular carcinoma. Transplantation 2008 85 10 1496 1499 2-s2.0-48649091347 10.1097/TP.0b013e31816feec0
35. Clavien P. A., Lesurtel M., Bossuyt P. M., Gores G. J., Langer B., Perrier A., OLT for HCC Consensus Group, Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report. The Lancet Oncology 2012 13 e11 e22
36. Bhangui P., Vibert E., Majno P., Salloum C., Andreani P., Zocrato J., Ichai P., Saliba F., Adam R., Castaing D., Azoulay D., Intention-to-treat analysis of liver transplantation for hepatocellular carcinoma: living versus deceased donor transplantation. Hepatology 2011 53 5 1570 1579 2-s2.0-79955115360 10.1002/hep.24231
37. Chen J., Huang K., Wu J., Zhu H., Shi Y., Wang Y., Zhao G., Survival after anatomic resection versus nonanatomic resection for hepatocellular carcinoma: a meta-analysis. Digestive Diseases and Sciences 2011 56 6 1626 1633 2-s2.0-79959306621 10.1007/s10620-010-1482-0
38. Poon R. T. P., Fan S. T., Lo C. M., Liu C. L., Lam C. M., Yuen W. K., Yeung C., Wong J., Extended hepatic resection for hepatocellular carcinoma in patients with cirrhosis: is it justified? Annals of Surgery 2002 236 5 602 611 2-s2.0-0036829825 10.1097/00000658-200211000-00010
39. Imamura H., Matsuyama Y., Tanaka E., Ohkubo T., Hasegawa K., Miyagawa S., Sugawara Y., Minagawa M., Takayama T., Kawasaki S., Makuuchi M., Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. Journal of Hepatology 2003 38 2 200 207 2-s2.0-0037308463 10.1016/S0168-8278(02)00360-4
40. Samuel M., Chow P. K., Chan Shih-Yen E., Machin D., Soo K. C., Neoadjuvant and adjuvant therapy for surgical resection of hepatocellular carcinoma. Cochrane Database of Systematic Reviews 2009 1, article CD001199 2-s2.0-62449228274
41. Abulkhir A., Limongelli P., Healey A. J., Damrah O., Tait P., Jackson J., Habib N., Jiao L. R., Preoperative portal vein embolization for major liver resection: a meta-analysis. Annals of Surgery 2008 247 1 49 57 2-s2.0-37549026473 10.1097/SLA.0b013e31815f6e5b
42. Croome K. P., Yamashita M. H., Laparoscopic vs open hepatic resection for benign and malignant tumors: an updated meta-analysis. Archives of Surgery 2010 145 11 1109 1118 2-s2.0-78449235505 10.1001/archsurg.2010.227
43. Livraghi T., Meloni F., Di Stasi M., Rolle E., Solbiati L., Tinelli C., Rossi S., Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: is resection still the treatment of choice? Hepatology 2008 47 1 82 89 2-s2.0-38649141497 10.1002/hep.21933
44. Cho Y. K., Kim J. K., Kim M. Y., Rhim H., Han J. K., Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies. Hepatology 2009 49 2 453 459 2-s2.0-61949290827 10.1002/hep.22648
45. Lencioni R., Loco-regional treatment of hepatocellular carcinoma. Hepatology 2010 52 2 762 773 2-s2.0-77955699976 10.1002/hep.23725
46. Tanaka S., Shimada M., Shirabe K., Taketomi A., Maehara S. I., Tsujita E., Ito S., Kitagawa D., Maehara Y., Surgical radiofrequency ablation for treatment of hepatocellular carcinoma: an endoscopic or open approach. Hepato-Gastroenterology 2009 56 93 1169 1173 2-s2.0-70350482160
47. Di Benedetto F., Tarantino G., Montalti R., Ballarin R., D'Amico G., Di Sandro S., Gerunda G. E., Laparoscopic radiofrequency ablation in the caudate lobe for hepatocellular carcinoma before liver transplantation. Journal of Laparoendoscopic & Advanced Surgical Techniques 2012 22 4 400 402 10.1089/lap.2011.0510
48. Cho Y. K., Kim J. K., Kim W. T., Chung J. W., Hepatic resection versus radiofrequency ablation for very early stage hepatocellular carcinoma: a markov model analysis. Hepatology 2010 51 4 1284 1290 2-s2.0-77950616331 10.1002/hep.23466
49. Chen M. S., Li J. Q., Zheng Y., Guo R. P., Liang H. H., Zhang Y. Q., Lin X. J., Lau W. Y., A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Annals of Surgery 2006 243 3 321 328 2-s2.0-33644662778 10.1097/01.sla. 0000201480.65519.b8
50. Cammà C., Di Marco V., Orlando A., Sandonato L., Casaril A., Parisi P., Alizzi S., Sciarrino E., Virdone R., Pardo S., Di Bona D., Licata A., Latteri F., Cabibbo G., Montalto G., Latteri M. A., Nicoli N., Craxì A., Treatment of hepatocellular carcinoma in compensated cirrhosis with radio-frequency thermal ablation (RFTA): a prospective study. Journal of Hepatology 2005 42 4 535 540 2-s2.0-20044364166 10.1016/j.jhep.2004.11.042
51. Tateishi R., Shiina S., Teratani T., Obi S., Sato S., Koike Y., Fujishima T., Yoshida H., Kawabe T., Omata M., Percutaneous radiofrequency ablation for hepatocellular carcinoma: an analysis of 1000 cases. Cancer 2005 103 6 1201 1209 2-s2.0-20044386501 10.1002/cncr.20892
52. Huang J., Yan L., Cheng Z., Wu H., Du L., Wang J., Xu Y., Zeng Y., A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria. Annals of Surgery 2010 252 6 903 912 2-s2.0-78650130194 10.1097/SLA.0b013e3181efc656
53. Morimoto M., Numata K., Kondou M., Nozaki A., Morita S., Tanaka K., Midterm outcomes in patients with intermediate-sized hepatocellular carcinoma: a randomized controlled trial for determining the efficacy of radiofrequency ablation combined with transcatheter arterial chemoembolization. Cancer 2010 116 23 5452 5460 2-s2.0-78649570066 10.1002/cncr.25314
54. Veltri A., Moretto P., Doriguzzi A., Pagano E., Carrara G., Gandini G., Radiofrequency thermal ablation (RFA) after transarterial chemoembolization (TACE) as a combined therapy for unresectable non-early hepatocellular carcinoma (HCC). European Radiology 2006 16 3 661 669 2-s2.0-33746612861 10.1007/s00330-005-0029-9
55. Forner A., Ayuso C., Varela M., Rimola J., Hessheimer A. J., De Lope C. R., Reig M., Bianchi L., Llovet J. M., Bruix J., Evaluation of tumor response after locoregional therapies in hepatocellular carcinoma: are response evaluation criteria in solid tumors reliable? Cancer 2009 115 3 616 623 2-s2.0-60049085346 10.1002/cncr.24050
56. Llovet J. M., Bruix J., Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology 2003 37 2 429 442 2-s2.0-0037308133 10.1053/jhep.2003.50047
57. Raoul J. L., Sangro B., Forner A., Mazzaferro V., Piscaglia F., Bolondi L., Lencioni R., Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: available evidence and expert opinion on the use of transarterial chemoembolization. Cancer Treatment Reviews 2011 37 3 212 220 2-s2.0-79952039170 10.1016/j.ctrv.2010.07.006
58. Varela M., Real M. I., Burrel M., Forner A., Sala M., Brunet M., Ayuso C., Castells L., Montañá X., Llovet J. M., Bruix J., Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics. Journal of Hepatology 2007 46 3 474 481 2-s2.0-33846847728 10.1016/j.jhep.2006.10.020
59. Lammer J., Malagari K., Vogl T., Pilleul F., Denys A., Watkinson A., Pitton M., Sergent G., Pfammatter T., Terraz S., Benhamou Y., Avajon Y., Gruenberger T., Pomoni M., Langenberger H., Schuchmann M., Dumortier J., Mueller C., Chevallier P., Lencioni R., Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION v study. CardioVascular and Interventional Radiology 2010 33 1 41 52 2-s2.0-77949264899 10.1007/s00270-009-9711-7
60. Cabibbo G., Enea M., Attanasio M., Bruix J., Craxì A., Cammá C., A meta-analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma. Hepatology 2010 51 4 1274 1283 2-s2.0-77950616983 10.1002/hep.23485
61. Luo J., Guo R. P., Lai E. C. H., Zhang Y. J., Lau W. Y., Chen M. S., Shi M., Transarterial chemoembolization for unresectable hepatocellular carcinoma with portal vein tumor thrombosis: a prospective comparative study. Annals of Surgical Oncology 2011 18 2 413 420 2-s2.0-79951556637 10.1245/s10434-010-1321-8
62. Kulik L. M., Carr B. I., Mulcahy M. F., Lewandowski R. J., Atassi B., Ryu R. K., Sato K. T., Benson A., Nemcek A. A., Gates V. L., Abecassis M., Omary R. A., Salem R., Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis. Hepatology 2008 47 1 71 81 2-s2.0-38649127852 10.1002/hep.21980
63. Kulik L. M., Atassi B., van Holsbeeck L., Souman T., Lewandowski R. J., Mulcahy M. F., Hunter R. D., Nemcek A. A., Abecassis M. M., Haines K. G., Salem R., Yttrium-90 microspheres (TheraSphere) treatment of unresectable hepatocellular carcinoma: downstaging to resection, RFA and bridge to transplantation. Journal of Surgical Oncology 2006 94 7 572 586 2-s2.0-33748798922 10.1002/jso.20609
64. Sangro B., Iñarrairaegui M., Bilbao J. I., Radioembolization for hepatocellular carcinoma. Journal of Hepatology 2012 56 2 464 473
65. Salem R., Lewandowski R. J., Kulik L., Wang E., Riaz A., Ryu R. K., Sato K. T., Gupta R., Nikolaidis P., Miller F. H., Yaghmai V., Ibrahim S. M., Senthilnathan S., Baker T., Gates V. L., Atassi B., Newman S., Memon K., Chen R., Vogelzang R. L., Nemcek A. A., Resnick S. A., Chrisman H. B., Carr J., Omary R. A., Abecassis M., Benson A. B., Mulcahy M. F., Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma. Gastroenterology 2011 140 2 497 507 2-s2.0-79251575901 10.1053/j.gastro.2010.10.049
66. Kang J. K., Kim M. S., Cho C. K., Stereotactic body radiation therapy for inoperable hepatocellular carcinoma as a local salvage treatment after incomplete transarterial chemoembolization. Cancer 2012 118 21 5424 5431 10.1002/cncr.27533
67. Takeda A., Takahashi M., Kunieda E., Takeda T., Sanuki N., Koike Y., Atsukawa K., Ohashi T., Saito H., Shigematsu N., Kubo A., Hypofractionated stereotactic radiotherapy with and without transarterial chemoembolization for small hepatocellular carcinoma not eligible for other ablation therapies: preliminary results for efficacy and toxicity. Hepatology Research 2008 38 1 60 69 2-s2.0-36549063071 10.1111/j.1872-034X.2007.00084.x
68. Tse R. V., Hawkins M., Lockwood G., Kim J. J., Cummings B., Knox J., Sherman M., Dawson L. A., Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Journal of Clinical Oncology 2008 26 4 657 664 2-s2.0-39149134352 10.1200/JCO.2007.14.3529
69. Kwon J. H., Bae S. H., Kim J. Y., Choi B. O., Jang H. S., Jang J. W., Choi J. Y., Yoon S. K., Chung K. W., Long-term effect of stereotactic body radiation therapy for primary hepatocellular carcinoma ineligible for local ablation therapy or surgical resection. Stereotactic radiotherapy for liver cancer. BMC Cancer 2010 10, article 475 2-s2.0-77956494929 10.1186/1471-2407-10- 475
70. Perz J. F., Armstrong G. L., Farrington L. A., Hutin Y. J. F., Bell B. P., The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. Journal of Hepatology 2006 45 4 529 538 2-s2.0-33748114343 10.1016/j.jhep.2006.05.013
71. Yang H. I., Lu S. N., Liaw Y. F., Hepatitis B e antigen and the risk of hepatocellular carcinoma. The New England Journal of Medicine 2002 347 168 174
72. Chan H. L. Y., Tse C. H., Mo F., Koh J., Wong V. W. S., Wong G. L. H., Chan S. L., Yeo W., Sung J. J. Y., Mok T. S. K., High viral load and hepatitis B virus subgenotype Ce are associated with increased risk of hepatocellular carcinoma. Journal of Clinical Oncology 2008 26 2 177 182 2-s2.0-38349094747 10.1200/JCO.2007.13.2043
73. Liaw Y. F., Sung J. J., Chow W. C., Lamivudine for patients with chronic hepatitis B and advanced liver disease. The New England Journal of Medicine 2004 351 1521 1531
74. Wong J. S. W., Wong G. L. H., Tsoi K. K. F., Wong V. W. S., Cheung S. Y. S., Chong C. N., Wong J., Lee K. F., Lai P. B. S., Chan H. L. Y., Meta-analysis: the efficacy of anti-viral therapy in prevention of recurrence after curative treatment of chronic hepatitis B-related hepatocellular carcinoma. Alimentary Pharmacology and Therapeutics 2011 33 10 1104 1112 2-s2.0-79954906552 10.1111/j.1365-2036.2011.04634.x
75. Raimondi S., Bruno S., Mondelli M. U., Maisonneuve P., Hepatitis C virus genotype 1b as a risk factor for hepatocellular carcinoma development: a meta-analysis. Journal of Hepatology 2009 50 6 1142 1154 2-s2.0-67349105629 10.1016/j.jhep.2009.01.019
76. Chen L. T., Chen M. F., Li L. A., Long-term results of a randomized, observation-controlled, phase III trial of adjuvant interferon Alfa-2b in hepatocellular carcinoma after curative resection. Annals of Surgery 2012 255 1 8 17
77. Sahin F., Kannangai R., Adegbola O., Wang J., Su G., Torbenson M., mTOR and P70 S6 kinase expression in primary liver neoplasms. Clinical Cancer Research 2004 10 24 8421 8425 2-s2.0-11144236505 10.1158/1078-0432.CCR-04-0941
78. Valdivieso A., Bustamante J., Gastaca M., Uriarte J. G., Ventoso A., Ruiz P., Fernandez J. R., Pijoan I., Testillano M., Suarez M. J., Montejo M., Ortiz de Urbina J., Management of hepatocellular carcinoma recurrence after liver transplantation. Transplantation Proceedings 2010 42 2 660 662 2-s2.0-77949440307 10.1016/j.transproceed.2010.02.014
79. Alamo J. M., Barrera L., Casado M. D., Bernal C., Marin L. M., Suarez G., Sanchez-Moreno L., Jimenez R., Suarez-Grau J. M., Sousa J. M., Cordero E., Gomez-Bravo M. A., Efficacy, tolerance, and safety of mammalian target of rapamycin inhibitors as rescue immunosuppressants in liver transplantation. Transplantation Proceedings 2009 41 6 2181 2183 2-s2.0-68949212217 10.1016/j.transproceed.2009.06.083
80. Vivarelli M., Dazzi A., Zanello M., Cucchetti A., Cescon M., Ravaioli M., Del Gaudio M., Lauro A., Grazi G. L., Pinna A. D., Effect of different immunosuppressive schedules on recurrence-free survival after liver transplantation for hepatocellular carcinoma. Transplantation 2010 89 2 227 231 2-s2.0-76649135180 10.1097/TP.0b013e3181c3c540
81. Söderdahl G., Bäckman L., Isoniemi H., Cahlin C., Höckerstedt K., Broomé U., Mäkisalo H., Friman S., Ericzon B. G., A prospective, randomized, multi-centre trial of systemic adjuvant chemotherapy versus no additional treatment in liver transplantation for hepatocellular carcinoma. Transplant International 2006 19 4 288 294 2-s2.0-33645345123 10.1111/j.1432-2277.2006.00279.x
82. Pokorny H., Gnant M., Rasoul-Rockenschaub S., Gollackner B., Steiner B., Steger G., Steininger R., Mühlbacher F., Does additional doxorubicin chemotherapy improve outcome in patients with hepatocellular carcinoma treated by liver transplantation? American Journal of Transplantation 2005 5 4 788 794 2-s2.0-16244410770 10.1111/j.1600-6143.2005.00780.x
83. Llovet J. M., Ricci S., Mazzaferro V., Hilgard P., Gane E., Blanc J. F., De Oliveira A. C., Santoro A., Raoul J. L., Forner A., Schwartz M., Porta C., Zeuzem S., Bolondi L., Greten T. F., Galle P. R., Seitz J. F., Borbath I., Häussinger D., Giannaris T., Shan M., Moscovici M., Voliotis D., Bruix J., Sorafenib in advanced hepatocellular carcinoma. The New England Journal of Medicine 2008 359 4 378 390 2-s2.0-47949116252 10.1056/NEJMoa0708857
84. European Association for the Study of the Liver, European Organisation for Research and Treatment of Cancer, EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. Journal of Hepatology 2012 56 4 908 943
85. Kim R., El-Gazzaz G., Tan A., Elson P., Byrne M., Chang Y. D., Aucejo F., Safety and feasibility of using sorafenib in recurrent hepatocellular carcinoma after orthotopic liver transplantation. Oncology 2010 79 1-2 62 66 2-s2.0-78149315368 10.1159/000319548
86. Yeganeh M., Finn R. S., Saab S., Apparent remission of a solitary metastatic pulmonary lesion in a liver transplant recipient treated with sorafenib. American Journal of Transplantation 2009 9 12 2851 2854 2-s2.0-72449198967 10.1111/j.1600-6143.2009.02860.x
87. Villanueva A., Llovet J. M., Targeted therapies for hepatocellular carcinoma. Gastroenterology 2011 140 5 1410 1426 2-s2.0-79955433548 10.1053/j.gastro.2011.03.006